Additionally, mutations in other genes such as Tumor Protein p53 (TP53), Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A), KIT, and Phosphatase and Tensin Homolog (PTEN) are implicated in the etiology and progression of MM (3, 53–55). This evidence concerns the gene PTEN and Miyoshi myopathy.